InvestSMART

Archer Materials Limited (ASX:AXE)

ALERT: Price-sensitive ASX Announcement for AXE
Current share price for AXE : $0.235 -0.045 (-16.07%)+
Announcement
Release
29 Apr 2026 9:31AM
Price at Release
$0.280
Full Release
download
Summary
Archer Materials Limited reported on its activities and financial status for the quarter ending 31 March 2026. The company focused on advancing its quantum technology platforms across computing, sensing, and medical diagnostics. Key achievements included progress in qubit development, scaling up carbon material growth for quantum devices, and developing a prototype for its quantum machine learning models aimed at fraud detection. An alpha-prototype of a blood potassium Biochip was also created, moving towards clinical trials and commercialization. Financially, Archer maintained a strong cash position of $10.3 million with no debt, supporting its research and development efforts. The company held discussions with partners like Emergence Quantum to bolster its technological advancements and is working towards commercializing its quantum technologies.
Key Points
  • Advancement in quantum qubit device development.
  • Progress in qubit readout and control capabilities.
  • Scaling up carbon material growth for device fabrication.
  • Completion of first phase of Quantum Machine Learning models for fraud detection.
  • Creation of alpha-prototype for blood potassium Biochip.
  • Strong cash position with $10.3 million and no debt.
  • Engagement with Emergence Quantum for graphene-based applications.
  • Focus on commercialization of quantum technologies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.